COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction
暂无分享,去创建一个
Robert A. Campbell | E. Beswick | Aaron C Petrey | M. Rondina | B. Manne | E. Middleton | F. Denorme | Kimberly Queisser | I. Portier | Aaron C. Petrey | Rebecca A. Mellema
[1] A. Orr,et al. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19 , 2021, Redox Biology.
[2] T. Omland,et al. SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19 , 2021, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
[3] J. Munson,et al. Hyaluronidase Impairs Neutrophil Function and Promotes Group B Streptococcus Invasion and Preterm Labor in Nonhuman Primates , 2021, mBio.
[4] Robert A. Campbell,et al. COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[5] H. Pavenstädt,et al. Microvascular dysfunction in COVID-19: the MYSTIC study , 2020, Angiogenesis.
[6] A. Engström‐Làurent,et al. Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? , 2020, The Journal of Biological Chemistry.
[7] R. Bordet,et al. Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19 , 2020, Circulation.
[8] A. Fabro,et al. Endothelial glycocalyx shedding in the acute respiratory distress syndrome after flu syndrome , 2020, Journal of Intensive Care.
[9] Robert A. Campbell,et al. COVID‐19 patients exhibit reduced procoagulant platelet responses , 2020, Journal of Thrombosis and Haemostasis.
[10] Robert A. Campbell,et al. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex , 2020, Journal of leukocyte biology.
[11] M. Ozawa,et al. Hyaluronan is abundant in COVID-19 respiratory secretions , 2020, medRxiv.
[12] Ying Song,et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China , 2020, Hypertension Research.
[13] K. Bosma,et al. Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation , 2020, Critical care explorations.
[14] T. Welte,et al. Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19 , 2020, American journal of respiratory and critical care medicine.
[15] P. Libby,et al. COVID-19 is, in the end, an endothelial disease , 2020, European heart journal.
[16] J. Newburger,et al. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.
[17] Michael D Healy,et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality , 2020, Nature Communications.
[18] Benjamin P. Kellman,et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 , 2020, bioRxiv.
[19] Oliver C. Grant,et al. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions , 2020, Antiviral Research.
[20] H. Krumholz,et al. Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.
[21] C. D. Dela Cruz,et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study , 2020, The Lancet Haematology.
[22] Robert A. Campbell,et al. Platelet gene expression and function in patients with COVID-19 , 2020, Blood.
[23] J. Rodríguez-Peralto,et al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases , 2020, The British journal of dermatology.
[24] L. Joosten,et al. Increased Plasma Heparanase Activity in COVID-19 Patients , 2020, Frontiers in Immunology.
[25] R. Claus,et al. Postmortem Examination of Patients With COVID-19. , 2020, JAMA.
[26] Axel Haverich,et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.
[27] M. Trauner,et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series , 2020, Annals of Internal Medicine.
[28] Kenar D. Jhaveri,et al. Acute kidney injury in patients hospitalized with COVID-19 , 2020, Kidney International.
[29] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[30] F. Crea,et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options , 2020, Cardiovascular research.
[31] J. Connors,et al. COVID-19 and its implications for thrombosis and anticoagulation , 2020, Blood.
[32] Norbert Stefan,et al. Obesity and impaired metabolic health in patients with COVID-19 , 2020, Nature Reviews Endocrinology.
[33] S. Susen,et al. Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence. , 2020, Circulation.
[34] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[35] G. Grasselli,et al. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis , 2020, Journal of Thrombosis and Haemostasis.
[36] I. Ziogas,et al. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past , 2020, Journal of Clinical Virology.
[37] T. West,et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.
[38] Y. Ho,et al. SARS-CoV-2: A Storm is Raging. , 2020, The Journal of clinical investigation.
[39] Ying Wang,et al. COVID-19 infection: the perspectives on immune responses , 2020, Cell Death & Differentiation.
[40] Lei Dong,et al. Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.
[41] Dengju Li,et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.
[42] B. Flamion,et al. Endothelial glycocalyx impairment in disease: Focus on hyaluronan shedding. , 2020, The American journal of pathology.
[43] S. Ohga,et al. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease. , 2019, International journal of cardiology.
[44] C. Heldin,et al. High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity , 2019, EBioMedicine.
[45] C. A. de la Motte,et al. Platelet Hyaluronidase-2 regulates the early stages of inflammatory disease in colitis. , 2019, Blood.
[46] M. Franchi,et al. Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer , 2019, The FEBS journal.
[47] O. Brand,et al. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis , 2019, Matrix biology : journal of the International Society for Matrix Biology.
[48] U. Desai,et al. Polymeric fluorescent heparin as one-step FRET substrate of human heparanase. , 2019, Carbohydrate polymers.
[49] Eric P. Schmidt,et al. The glycocalyx: a novel diagnostic and therapeutic target in sepsis , 2019, Critical Care.
[50] J. Lekakis,et al. Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives , 2018, Journal of clinical hypertension.
[51] P. McGuire,et al. Cathepsin D plays a role in endothelial–pericyte interactions during alteration of the blood–retinal barrier in diabetic retinopathy , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] M. Wurfel,et al. Hyaluronic acid is associated with organ dysfunction in acute respiratory distress syndrome , 2017, Critical Care.
[53] D. Fatovich,et al. Endothelial glycocalyx biomarkers increase in patients with infection during Emergency Department treatment , 2017, Journal of critical care.
[54] N. Ogasawara,et al. Serum-Derived Hyaluronan-Associated Protein Is a Novel Biomarker for Inflammatory Bowel Diseases , 2017, Digestion.
[55] C. A. de la Motte,et al. Thrombin Cleavage of Inter-α-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix*♦ , 2016, The Journal of Biological Chemistry.
[56] I. Douglas,et al. Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome. , 2016, American journal of respiratory and critical care medicine.
[57] L. M. Srivastava,et al. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients. , 2016, Clinical biochemistry.
[58] M. Jacob,et al. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases , 2015, British journal of clinical pharmacology.
[59] D. Laskowski,et al. Hyaluronan and Its Heavy Chain Modification in Asthma Severity and Experimental Asthma Exacerbation* , 2015, The Journal of Biological Chemistry.
[60] C. Page,et al. The Role of Heparanase in Pulmonary Cell Recruitment in Response to an Allergic but Not Non-Allergic Stimulus , 2015, PloS one.
[61] F. Tsai,et al. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. , 2015, Circulation research.
[62] K. Pyrć,et al. Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells , 2014, Journal of Virology.
[63] I. Douglas,et al. The Circulating Glycosaminoglycan Signature of Respiratory Failure in Critically Ill Adults* , 2014, The Journal of Biological Chemistry.
[64] M. Bodelsson,et al. Circulating glycosaminoglycan species in septic shock , 2014, Acta anaesthesiologica Scandinavica.
[65] R. Goldberg,et al. Versatile role of heparanase in inflammation. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[66] Jian Liu,et al. Multi-faceted substrate specificity of heparanase. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[67] A. Harvey,et al. An improved assay for the spectrophotometric determination of chondroitinase ABC activity , 2013 .
[68] R. Forteza,et al. Hyaluronan and Layilin Mediate Loss of Airway Epithelial Barrier Function Induced by Cigarette Smoke by Decreasing E-cadherin* , 2012, The Journal of Biological Chemistry.
[69] Yimu Yang,et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis , 2012, Nature Medicine.
[70] Chengyu Jiang,et al. Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans , 2011, PloS one.
[71] C. A. de la Motte,et al. Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. , 2009, The American journal of pathology.
[72] D. Schwartz,et al. Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury. , 2008, American Journal of Respiratory and Critical Care Medicine.
[73] K. Stuhlmeier. Hyaluronan Production in Synoviocytes as a Consequence of Viral Infections , 2008, Journal of Biological Chemistry.
[74] P. Kubes,et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids , 2008, The Journal of experimental medicine.
[75] K. Peter,et al. Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional Ischemia , 2007, Circulation.
[76] S. Harper,et al. A Role for the Endothelial Glycocalyx in Regulating Microvascular Permeability in Diabetes Mellitus , 2007, Cell Biochemistry and Biophysics.
[77] Dick W. Slaaf,et al. The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.
[78] Shwu-Fan Ma,et al. Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation , 2006, Journal of Biological Chemistry.
[79] M. J. Jedrzejas,et al. Hyaluronidases: their genomics, structures, and mechanisms of action. , 2006, Chemical reviews.
[80] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[81] A. Moustakas,et al. Hyaluronan Fragments Induce Endothelial Cell Differentiation in a CD44- and CXCL1/GRO1-dependent Manner*boxs , 2005, Journal of Biological Chemistry.
[82] J. Simon,et al. Hyaluronan Fragments Stimulate Endothelial Recognition of Injury through TLR4* , 2004, Journal of Biological Chemistry.
[83] J. Platt,et al. Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 41 , 2004, The Journal of Immunology.
[84] J. Platt,et al. Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41 , 2002, The Journal of Immunology.
[85] E. Puré,et al. Resolution of Lung Inflammation by CD44 , 2002, Science.
[86] C. A. de la Motte,et al. Mononuclear Leukocytes Preferentially Bind via CD44 to Hyaluronan on Human Intestinal Mucosal Smooth Muscle Cells after Virus Infection or Treatment with Poly(I·C)* , 1999, The Journal of Biological Chemistry.
[87] T. Laurent,et al. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. , 1989, The American review of respiratory disease.
[88] J. Burns,et al. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. , 1984, The Journal of pediatrics.
[89] C. A. de la Motte,et al. Analysis of the heavy-chain modification and TSG-6 activity in pathological hyaluronan matrices. , 2015, Methods in molecular biology.
[90] Frances E. Lennon,et al. Hyaluronan regulation of vascular integrity. , 2011, American journal of cardiovascular disease.
[91] R. Poupon,et al. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. , 1995, Journal of hepatology.
[92] C. A. de la Motte,et al. Copyright © American Society for Investigative Pathology Mononuclear Leukocytes Bind to Specific Hyaluronan Structures on Colon Mucosal Smooth Muscle Cells Treated with Polyinosinic Acid:Polycytidylic Acid Inter-�-Trypsin Inhibitor Is Crucial to Structure , 2022 .